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Abstract
Background: Previous research and key guidelines have suggested potential models of palliative care for patients
with COPD and interstitial lung disease. However, these recommendations are often not effectively implemented in
clinical practice and are void of guidance regarding palliative care for patients with bronchiectasis, another form of
non-malignant respiratory disease. The aim of this research was to explore generalist and specialist palliative care
service provision for people with non-malignant respiratory disease in the North and Republic of Ireland.
Methods: Qualitative study involving a convenience sample of 17 bereaved carers and 18 healthcare professionals
recruited from 2 rural and 2 urban sites on the Island of Ireland. Data collection consisted of semi-structured interviews
with carers of patients with COPD, interstitial lung disease or bronchiectasis who had died 3–18 months previously;
and 4 focus groups with healthcare professionals. Data analysed using thematic analysis.
Results: Findings highlighted the lack of a clear model of holistic care delivery for patients with non-malignant respiratory
disease and illuminated the varying levels of palliative care provision this client group experienced. Additionally, ambiguity
amongst healthcare professionals regarding prognostication illuminated the importance of the provision of palliative care
being based on patient need, not prognosis. This research developed a potential model of palliative care which may help
healthcare professionals introduce palliative care, and specialist respiratory care, early in the disease trajectory of non-
malignant respiratory disease, whilst also encouraging the involvement of specialist palliative care for complex symptom
management.
Conclusion: This research provides an important insight into a potential model of palliative care for people with non-
malignant respiratory disease, inclusive of bronchiectasis. However, the feasibility of integrating this model into clinical
practice requires further exploration.
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Background
The World Health Organisation [1] highlighted that in
2012 more than 3 million people died of COPD, which
globally represented 6% of all deaths that year. Although
confirmability data are not available it is estimated that
the extent of other non-malignant respiratory diseases
(NMRDs), such as interstitial lung disease (ILD) and
bronchiectasis, are a growing global health problem [2].
Within Europe, it is estimated that mortality rates of
ILD are approximately 2.5 per 100,000 people per year
[3]. In the United Kingdom (UK) it was highlighted that
there were 1.68 deaths from bronchiectasis per 100,000
population in 2007, with the mortality rate increasing by
approximately 3% per year [4]. Patients with NMRD
should receive a palliative approach to their care, even if
they are still actively receiving treatment to slow or sta-
bilise their illness [5]. Although NMRD is on the in-
crease internationally and nationally evidence suggested
that patients with NMRD often do not receive optimum
holistic care [6], or the same standards of palliative care
as patients with malignant respiratory disease [7, 8].
However this research [7, 8] focused on patients with a
diagnosis of COPD and their carers, and not those with
ILD or Bronchiectasis.
The palliative care provided by healthcare profes-
sionals (HCPs) that specialise in this area is known as
specialist palliative care, and these professionals provide
palliative expertise, services and resources [9]. Palliative
care delivered by HCPs who are not classified as special-
ist palliative care providers is known as generalist pallia-
tive care [10]. There are several key strategic drivers
within Northern Ireland (NI) [11, 12] and the Republic
of Ireland (ROI) [13–15] that have highlighted the need
for generalist and specialist palliative care provision for
patients with NMRD. However, there is a lack of consen-
sus amongst national [16] and international [17–22]
guidelines regarding palliative care for patients with
NMRD and their carers. These strategic documents are
also void of guidance regarding palliative care for
patients with bronchiectasis. Specialist respiratory HCPs
also have a key role in the provision of generalist pallia-
tive care to patients with NMRD [16]. Specialist respira-
tory services for patients with a malignant or
non-malignant respiratory condition consist of HCPs
specialised in respiratory care that include respiratory
nurse specialists, respiratory consultants and allied
health professionals. The provision of specialist respira-
tory services for patients with NMRD varies throughout
the North and Republic of Ireland, with these services
being more readily available in the primary care setting
in NI [11] in comparison to the ROI [23]. The majority
of specialist respiratory services in the ROI are based in
the secondary care setting. The coordination and avail-
ability of specialist respiratory, specialist palliative care
and generalist palliative care services differ across the
North and Republic of Ireland, especially within the pri-
mary care setting.
Aim
The aim was to explore generalist and specialist pallia-
tive care service provision for people with NMRD in the
North and Republic of Ireland.
Methods
Design
The design of this study involved two methods of data
collection: semi- structured interviews with bereaved
carers of patients with NMRD, and focus groups with
HCPs involved in their care. Due to the exploratory na-
ture of this research a broad interpretivist approach was
utilised by the researcher. Interpretivist researchers
believe that by interacting with the world around them
people attach their own meanings and values to their ex-
periences, therefore broad interpretivism attempts to
explore this to provide a deeper understanding of the
topic being researched [24]. Something that must be
considered in qualitative research when discussing the
research process is reflexivity. The main researcher
(C.V) was a registered nurse with 10 years experience
caring for patients with palliative care needs.
Settings and participants
A total of 17 bereaved carers and 18 HCPs were re-
cruited from 1 rural and 1 urban site in NI, and 1 rural
and 1 urban site in the ROI using convenience sampling.
In NI, the research involved bereaved carers and HCPs
in the Northern Health and Social Care Trust (NHSCT)
and the Belfast Health and Social Care Trust (BHSCT).
In the ROI, bereaved carers and HCPs were recruited
from Letterkenny, Co. Donegal and Dublin. Belfast is ac-
knowledged as an urban area in NI [25] and Dublin is
recognised as an urban location in the ROI [26]. The
NHSCT covers a large rural area in NI [27] and Letter-
kenny is part of a rural county in the ROI [28]. Figures 1
and 2 illustrate the recruitment process. Tables 1 and 2
provide the sociodemographic details of interview and
focus group participants. As noted within Table 1, the
majority of carers were female (n = 14) and all carers
were family members. Eligibility criteria for participation
in the semi-structured interviews identified bereaved
carers, ascertained by a respiratory nurse specialist
(RNS) as the main carer, of people with NMRD who had
died 3 to 18 months previously. Bereaved carers were
identified from the patients’ documentation, and re-
cruited, by the RNS in both the secondary and primary
care setting. This group of participants were chosen as
the researcher felt they would not only give an insight
into the patient’s palliative care throughout their illness,
Veigh et al. BMC Palliative Care  (2018) 17:6 Page 2 of 12
but also their own experiences as a carer. Bereaved
carers were also used as proxies for the patient as they
were able to provide a post-death account that also took
into consideration the palliative care that was provided
to the patient at the end of life [29]. The period of time
was chosen as although it was not straight after the
death of the participant’s relative, it was within a time
frame that allowed them to remember their experience
and also reduced trauma to the participant. Carers under
18 years of age, who did not speak English or were too
distressed to take part in a research study, were ex-
cluded. Eligibility criteria for the focus groups included
HCPs involved in the generalist and specialist palliative
care of patients with NMRD, in the primary and second-
ary care setting. Permission to access staff was sought
from the various relevant heads of each department e.g.
director of nursing, respiratory consultant etc., in the areas
involved in the study and they also aided recruitment.
Data collection
Semi-structured interviews (Additional file 1: Box 1) were
conducted in bereaved carers’ homes (n = 10), or over
the telephone (n = 7). The choice of telephone or face-
to-face was offered to participants to allow them to
choose an interview method that was most convenient
for them. Research has previously highlighted that be-
reaved family members interviewed over the telephone
did not report any concerns or limitations associated
with this data collection method [30, 31]. Interviews
ranged from 22 to 80 min in length, with an average of
Fig. 1 Flowchart of recruitment and retention for semi-structured interviews with bereaved carers
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50 min. Healthcare professional focus groups (n = 4)
(Additional file 2: Box 2) were conducted with partici-
pants from the primary and secondary care setting at
each area involved in the study. Focus groups ranged
from 68 to 81 min in length, with an average of 74 min.
All interviews and focus groups were digitally recorded
and transcribed verbatim. Interviews and focus groups
were conducted by one author (C.V) who had appropri-
ate training on conducting qualitative research. In order
to aid the accurate recording of the focus groups, an
additional member of the research team fulfilled the role
of note taker (J.R). Data collection was completed when
it was noted by the researcher that no new themes or in-
formation were emerging from the data.
Analysis
Data were analysed by adopting King and Horrock’s [32]
approach to thematic analysis. The qualitative research
software package NVivo was used to allow for the man-
agement of the dataset, whilst also facilitating an in-
creased focus on effectively analysing the data [33].
Initial data analysis consisted of the exploration of each
interview and focus group to develop descriptive themes.
Descriptive themes generate a list of emerging categor-
ies, or topics, from the data but do not offer an
interpretation of their meanings [34]. Analysis then pro-
gressed to focusing on the interpretation of the meaning
of the data [32] through grouping together the descrip-
tive themes to highlight emerging interpretative themes.
Finally, overarching themes were developed by linking
all the interpretative themes that had been established.
Each transcription was initially analysed by C.V and then
reviewed separately by the remaining authors (P.H, J.R,
P.L and S.P). All themes and transcripts were then
discussed collaboratively by the research team for verifi-
cation of the themes generated, and agreement was
Fig. 2 Flowchart of recruitment and retention for focus groups with healthcare professionals
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reached regarding the final themes. Preliminary findings
were also presented at various academic conferences and
clinical meetings which provided further opportunities
for feedback and critical discussions.
Ethics
All participation was voluntary with full written, and
verbal, informed consent. Ethical approval was received
from the Office of Research and Ethics Committee
Northern Ireland (ORECNI, Reference: 11/NI/0166) and
governance permission from the Northern Health and
Social Care Trust (Reference: NRP11–0264/09), Belfast
Health and Social Care Trust (Reference:11080JR-AS),
Letterkenny and Dublin.
Semi-structured interviews findings
Analysis of the carers’ interviews identified the key
overarching theme: lack of consistency in palliative
care delivery, developed from the interpretative
themes outlined below and illustrated through partici-
pants’ quotes.
Lack of consistency in palliative care delivery
The overarching theme of lack of consistency in pallia-
tive care delivery identified interpretative themes of
‘variations in the delivery of specialist palliative care’ and
Table 1 Bereaved carer participant profiles
Participants of the semi-structured interviews
Gender Women: 14 bereaved carers
Men: 3 bereaved carers
Age Mean: 58.2 years
Median: 55 years
Range: 41–81 years
Relation to patient Daughter (n = 5)
Son (n = 2)
Wife (n = 7)
Partner (n = 1)
Daughter in-law (n = 1)
Nephew (n = 1)
Patient and carer living together Yes (n = 10)
No (n = 7)
Occupation Residential home manager (n = 1)
Unemployed (n = 3)
Retired (n = 6)
Classroom Assistant (n = 1)
Housewife (n = 3)
Probation Officer (n = 1)
Porter (n = 1)
Health and Safety Officer (n = 1)
Time post bereavement Mean: 7 months
Median: 6 months
Range: 4–17 months
Area Northern Ireland (n = 10)
Republic of Ireland (n = 7)
Rural (n = 8)
Urban (n = 9)
Diagnosis COPD (n = 12)
Interstitial Lung Disease (n = 4)
Bronchiectasis (n = 1)
Interview Type Face to Face (n = 10)
Telephone (n = 7)
Table 2 Healthcare professional participant profiles from primary
and secondary care setting
Participant Occupation Years of Experience
in Current Role
Focus Group 1 (Urban, NI)
OT1 Specialist palliative care
Occupational Therapist
20 years
RN1 Respiratory Nurse Specialist 5 years
PCN1 Palliative Care Nurse Specialist 7 years
PCC1 Specialist palliative care Consultant 13 years
PCN2 Specialist palliative care Nurse
Consultant
23 years
RC1 Respiratory Consultant 15 years
Focus Group 2 (Rural, NI)
RN2 Respiratory Nurse Specialist 13 years
RN3 Respiratory Ward Manager 10 years
RC2 Respiratory Consultant 5 years
RN4 Respiratory Nurse Specialist 5 years
PCN3 Palliative Care Inpatient unit
Deputy Ward Manager
32 years
Focus Group 3 (Rural, ROI)
RN5 Respiratory Clinical Nurse
Specialist
6 years
PCN4 Palliative Care Clinical Nurse
Specialist
11 years
PH Physiotherapist 11 years
Focus Group 4 (Urban, ROI)
RN6 Respiratory Clinical Nurse
Specialist
20 years
RN7 Respiratory Clinical Nurse
Specialist
12 years
RN8 Respiratory Deputy Ward
Manager
6 years
PCN5 Palliative Care Clinical Nurse
Specialist
12 years
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‘variations in the delivery of palliative care from special-
ist respiratory services.’
Variations in the delivery of specialist palliative care
Amongst the 17 carers that were interviewed, 6 stated
that the patient they cared for had received specialist
palliative care input. Specialist palliative care was
viewed by participants as care being delivered by
HCPs who identified themselves as being specifically
trained in delivering palliative care. The remaining 11
carers stated that, to the best of their knowledge, the
patient had not received input from a specialist pallia-
tive care provider. Out of the 6 who perceived that
the patient had received specialist palliative care, 2
had a diagnosis of ILD and 4 had a diagnosis of
COPD. Carers who reported the patient as having re-
ceived specialist palliative care expressed that these
services were only introduced when the patient was
nearing the end of their life:
“[Specialist] Palliative care was only introduced the
week he died so that didn’t even really get off the
ground.” (BC17, p4).
The absence of specialist palliative care providers was
also recognised and discussed by some carers who
highlighted that they would have preferred these services
to be involved in patients’ care:
“We would have liked palliative care were you
would have a qualified nurse coming in who knew
exactly what was happening here. I feel we would
have benefited greatly from that. But we didn’t have
that.” (BC1, p13).
Carers’ experiences highlighted their perceptions
that the early introduction of specialist palliative
care may have been of benefit to the patient with
NMRD.
Variations in the delivery of palliative care from specialist
respiratory services
The provision of palliative care to patients with NMRD
by specialist respiratory services was also illuminated by
carers. In the ROI services from a RNS were available in
the secondary care setting and not the primary care set-
ting. Carers in the ROI perceived that the receipt of ser-
vices from a RNS would have been of benefit to the
patient in the community:
“I think maybe if he had someone coming to him once
a month or every three weeks like a respiratory nurse, I
would have liked them to be more involved but they don't
have services like that here.” (BC3, p2).
Carers within the ROI perceived that patients with
NMRD received adequate specialist respiratory care for
their palliative needs when in hospital, but this care was
not continued when the patient was discharged back
into the community:
“Well she didn’t really have any care at home apart
from when she took sick and went into hospital. Then she
was seen by doctors and nurses but nothing at home. She
would have seen the respiratory nurse but that was only
up at the hospital.” (BC10, p1).
In contrast to the views expressed by carers in the
ROI, in NI perceptions were that patients with NMRD
had sufficient input from the RNS in the primary care
setting:
“Like if it was anytime during the day I would have
just rang up the respiratory nurse and there was always
someone there to help me.” (BC14, p4).
Variances in the provision of specialist respiratory care
services for patients with NMRD were therefore indi-
cated by the accounts provided by carers.
Focus group findings
Two overarching themes emerged from analysis of the
HCPs’ interviews: barriers to providing appropriate pal-
liative care and future direction of palliative care for pa-
tients with NMRD. Overarching themes originated from
the interpretative themes outlined below and illustrated
through participants’ quotes.
Barriers to providing appropriate palliative care
The overarching theme of barriers to providing appro-
priate palliative care identified interpretative themes of
‘lack of prognostic certainty’ and ‘Lack of understanding
of the role of palliative care in relation to patients with
NMRD.’
Lack of prognostic certainty
Across the North and ROI, varying HCPs perceived
that uncertainty regarding the trajectory of NMRD
inhibited the timely provision of palliative care to this
client group:
“I think that the disease [NMRD] can be palliative
from a much earlier stage and I am not sure how good
we are at that, I think someone could be palliative from
their first referral to the clinic and they might take five
years to die. Prediction is often difficult; it is a little bit
easier with pulmonary fibrosis as the line of trajectory
tends to be more acute. And very difficult in Bronchiec-
tasis, it’s only after several runs of treatment that you
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realise that this isn’t working. I think we often kind of
look back and think could I have spotted something six
months ago? I always ask myself are we late into the
game of palliation?” (RC1, Respiratory Consultant, p4).
“With lung cancer patients you can give a rough prog-
nosis and know when to introduce palliative care. With
patients with COPD there is no definitive timeline and
they can be up and down so there is no obvious point
where you know to definitely involve palliative care so
that is the big issue really.” (RN8, Respiratory Deputy
Ward Manager, p8).
Difficulties regarding prognostication due to the
clinical manifestations of NMRD, particularly COPD and
bronchiectasis, were highlighted as resulting in the
delayed introduction of palliative care in the disease
trajectory.
Lack of understanding of the role of palliative care in
relation to patients with NMRD
Healthcare professionals’ perceived that specialist
palliative care was often still only associated with malig-
nant disease, and therefore HCPs did not recognise the
important role it had in NMRD:
“You know awareness is improving but there still are
professionals who are surprised and will say, “That
patient is respiratory they haven’t got cancer so why are
you seeing them?” So there is still a gap in the awareness
even among professionals.” (PCN4, Palliative Care Nurse
Specialist, p5).
Participants in NI and the ROI additionally suggested
that specialist palliative care providers viewed patients
with a malignant diagnosis as having priority over those
with NMRD:
“You know I have had fights and struggles with the spe-
cialist palliative care team because they see cancer as a
priority and not respiratory and they don’t understand
that these people have palliative needs too and therefore
they wouldn’t prioritise them as much for the Marie Curie
sit in service.” (RN2, Respiratory Nurse Specialist, p4).
The views expressed by HCPs in the ROI additionally
indicated an inequality of generalist and specialist pallia-
tive care service provision for patients with ILD or
bronchiectasis, in comparison to COPD:
“Bronchiectasis patients are left to self -manage at
home and I would say that the COPD patients are
getting a better [specialist and generalist] palliative care
service than the other cohorts [ILD and bronchiectasis].”
(RN7, Respiratory Nurse Specialist, p9).
“I suppose from what I have seen it is mostly NMRD
patients with COPD that get seen by specialist palliative
care and I haven’t had any bronchiectasis patients that
have been seen or referred to specialist palliative care
that I am aware of.” (PH, Physiotherapist, p8).
Healthcare professionals’ accounts illuminated how a
perceived lack of understanding amongst HCPs in
relation to the role of palliative care for patients with
NMRD, created a barrier to optimal service provision.
Future direction of palliative care for patients with NMRD
The overarching theme of future direction of palliative
care for patients with NMRD identified interpretative
themes of ‘who will provide palliative care?’ and ‘the
presence of a model for palliative care delivery in
NMRD.’
Who will provide palliative care?
When discussing the future provision of palliative care
to patients with NMRD in the North and ROI, HCPs
presented varied views on who should be involved in the
delivery of palliative care to this client group. Some
medical and nursing HCPs expressed that the involve-
ment of specialist palliative care providers was a neces-
sity for patients with NMRD:
“I would rather if I had a condition like NMRD I
would probably prefer to have a specialist palliative care
consultant than a generalist respiratory physician that
has had some experience in palliative care.” (RC2,
Respiratory Consultant, p12).
Allied and nursing HCPs perceived that increased in-
volvement of specialist palliative care services equated in
reduced numbers of emergency admissions for patients
with NMRD:
“And I know it is far and few between but the [NMRD]
patients who have seen specialist palliative care maybe
not coming in as much to accident and emergency as
they are not panicking and so therefore specialist
palliative care can make a big difference.” (PH, Physio-
therapist, p6).
“I think nursing homes sometimes send (NMRD)
patients in (to hospital) without really getting someone to
see why they need to be sent into hospital because they
do tend to sit in accident and emergency for hours un-
necessarily. You know I think if the hospice nurse did go
in to have a look then a lot of the admissions could be
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avoided.” (PCN3, Palliative Care Inpatient Unit Deputy
Ward Manager, p10).
Participants from the varying healthcare professions
additionally conveyed that specialist palliative care in-
volvement was necessary when a patient with NMRD
developed complex symptom needs:
“I know my limitations in terms of symptomatically what
can the girls [specialist palliative care nurses] bring in that
we [RNS] perhaps wouldn’t even consider and therefore I
think that specialist palliative care is required on that
account.” (RN7, Respiratory Nurse Specialist, p8).
However HCPs additionally illuminated that the deliv-
ery of holistic care to patients with NMRD was part of
the role of all generalist palliative care providers:
“I think that in some of these NMRD patients the fact
that they have a chronic disease may not mean that they
need specialist palliative care but certainly a palliative
approach is needed and is all our responsibilities regardless
of our qualifications.” (PCN4, Palliative Care Nurse
Specialist, p5).
Healthcare professionals’ accounts highlighted mixed
perspectives on the specific role of specialist palliative
care services, and when they should be introduced for
patients with NMRD.
The presence of a model for palliative care delivery in
NMRD
A model of palliative care for patients with NMRD can help
to ensure they receive appropriate palliative care when it is
needed. This was perceived by participants in NI:
“Well there is the ELCOS (End of Life Care Operational
System) Model for palliative care used for respiratory
palliative care and that is regional and it moves from
early to late phase and tells you what the patient should
be getting at each stage. And I suppose with the model
everything is there and you know what’s available and
what you should be doing and us a team can look and
see what we need to be doing.” (RN2, Respiratory Nurse
Specialist, p14).
Within the ROI however participants highlighted that
there was not a regional model for palliative care that
could help to guide the delivery of palliative care to
patients with NMRD:
“We don’t have a model for either delivering palliative
care or respiratory care and I suppose we should.” (RN5,
Respiratory Nurse Specialist, p8).
Discussion
The present study highlighted carers’ perceptions that
patients with NMRD wanted access to specialist pallia-
tive care services however service availability was often
uncoordinated and varied. Research has highlighted this
previously amongst patients with ILD [35–37] and
COPD [38]. The present study however additionally dis-
covered that patients with bronchiectasis also experi-
enced a lack of involvement from specialist palliative
care providers. The integration of early specialist pallia-
tive care can help alleviate the symptoms experienced by
patients with COPD and ILD [39].
Prognostic uncertainty experienced by HCPs impacted
on the referral of patients with NMRD to specialist pal-
liative care services. Crawford et al. [40] discovered that
often referrals to specialist palliative care services were
linked to how long a patient with COPD had left to live,
rather than their holistic symptom needs. This implies
that HCPs may be reluctant to refer patients for special-
ist palliative care input if they are unsure how their
disease is progressing. Healthcare professionals must
make referrals to specialist palliative care based on a
needs assessment of the patient’s bio-psychosocial symp-
toms. This should not just be based on when the patient
will die, to ensure optimal management of their holistic
needs. By predicting needs instead of prognosis, patients
with NMRD could be delivered more proactive palliative
care [14, 41].
Research comparing access to specialist palliative care
services between patients with NMRD and lung cancer,
internationally and within the UK, indicated that
patients with COPD and ILD have less access to special-
ist palliative care services than patients with lung cancer
[7, 8, 42]. It has been previously suggested that this may
be a result of HCPs associating palliative care with
malignant disease [7, 8]. Present findings added a
novel perspective by further highlighting that this is
also a misconception associated with bronchiectasis,
not just COPD and ILD. If HCPs are unaware of the
role palliative care has in the care of patients with
NMRD then this will impact on the services this cli-
ent group receives.
Healthcare professionals additionally indicated that pa-
tients with COPD may more commonly receive general-
ist and specialist palliative care than those with a
diagnosis of ILD or bronchiectasis. Previous literature
acknowledged the importance of palliative care for pa-
tients with bronchiectasis [43, 44] and ILD [35, 36]. Baj-
wah et al. [35] also highlighted that the important role
of palliative care in ILD was not always recognised in
the UK as it was not a malignant disease. Within the
present study however, it was additionally evidenced that
inequalities related to the recognition of the role of pal-
liative care may also be seen amongst different types of
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non-malignant disease, and not just between cancer and
non-cancer diagnoses. Patients with COPD are less likely
to get referred for specialist palliative care than patients
with other non-malignant disease such as heart failure
and severe dementia [38]. It is important that HCPs rec-
ognise that the provision of palliative care to patients
with NMRD must be based on need [14], to ensure the
effective provision of palliative care that is responsive to
the patient’s symptom complexities.
Focus group findings presented various views on how
future palliative care should be delivered to patients with
NMRD. Some HCPs highlighted that specialist palliative
care should be provided to all patients with NMRD.
International guidance has recognised that palliative care
should be delivered by generalist HCPs, and specialist
palliative care providers should be involved in a patients
care when their symptoms become increasingly complex
[21]. However research conducted in the UK advocated
the integration of early specialist palliative care for pa-
tients with ILD and COPD, and provided evidence that
it helped improve the mastery of breathlessness experi-
enced by these patients [39]. Guidelines within the UK
have also recommended the introduction of specialist
palliative care services for patients with ILD from the
point of diagnosis [18]. Policies specific to bronchiectasis
however do not provide guidance on the introduction of
these services [18, 22].
In line with international views [45], and previous re-
search [46], many HCPs expressed that specialist pallia-
tive care should only be introduced when generalists
find it difficult to manage the bio-psychosocial symp-
toms of patients with NMRD. Policy [19], research [47]
and international guidelines [21, 48] have advocated the
efficacy of specialist palliative care services being intro-
duced when patients with advanced COPD and ILD
develop complex symptoms. However there is a lack of
consistent guidance for HCPs involved in the care of pa-
tients with NMRD, regarding the palliative service
provision required by this client group.
For some HCPs, within the present study, the reason-
ing behind championing the role of specialist palliative
care for patients with NMRD was due to its perceived
impact on reducing unplanned hospital admissions. Pre-
vious research highlighted that significant decline in ad-
missions for COPD exacerbations may have been
aligned with specialist palliative care services providing
palliative care to this client group [49]. The present
study concurs with these findings as some HCPs felt that
patients with NMRD who received specialist palliative
care were less likely to attend accident and emergency
departments, or have unplanned admissions to hospital.
This may be due to perceptions that patients with
NMRD who have specialist palliative care teams involved
in their care will have more effective symptom
management [39], and can therefore be effectively man-
aged within their preferred place of care.
Previous research has identified varying potential
models of palliative care for patients with ILD and COPD
[19, 20, 39, 46]. However, previous policy documents and
research have been void of guidance regarding a model of
palliative care for patients with bronchiectasis. Addition-
ally, if patients’ holistic symptom needs were treated ra-
ther than their prognosis or diagnoses anyone with a life
limiting illness would get help when needed e.g. patients
with bronchiectasis or other rare diseases that will rarely
be thought of as needing palliative care. Findings from the
present study highlighted that HCPs might have benefited
from a model of care to guide the provision for palliative
care for patients with NMRD that emphasised the import-
ance of introducing holistic care early in the disease
trajectory, and ensuring it is needs based. Figure 3 demon-
strates a potential model of palliative care for patients with
NMRD derived from the findings of the present study.
This model proposes three levels of palliative care for
patients with ILD, COPD and bronchiectasis whilst
advocating the continued holistic assessment of pa-
tient need. Level one advocates a holistic approach to
care which is introduced from diagnosis of NMRD.
This care should be delivered by both generalist pal-
liative care and specialist respiratory care providers.
As symptom complexities increase, level two suggests
that HCPs must additionally assess the need for the
introduction of specialist palliative care services. The
proposed model indicates that this decision should be
based on HCPs feeling they need further support or
guidance to manage the patient’s symptoms. If the
patient develops complex symptoms that generalist
palliative care and specialist respiratory care providers
perceive they are no longer able to effectively manage,
then level three of the model proposes that timely
referral to specialist palliative care services is neces-
sary. The patient may move between levels at
different points within their trajectory and this should
be based on the assessment of their needs and
symptom complexities.
With regard to future research, an interesting exten-
sion of this study would be adopting the Medical
Research Council (MRC) framework for complex inter-
ventions [50] in order to develop and ratify the potential
model of palliative care derived from the findings of this
study. This would initially involve conducting a feasibil-
ity study with respiratory teams to explore the practical-
ities of implementing the proposed model of palliative
care for patients with ILD, COPD and bronchiectasis.
The next stage would be interventional research to pro-
vide in depth information regarding the implications of
introducing a model of care into the palliative care of
patients with NMRD. This stage would focus on testing
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the intervention based on the data gained from the feasi-
bility study. This intervention study could be modelled
on previous research that has explored the implemen-
tation of models of palliative care for patients with
breathlessness [51], ILD and COPD [39] and lung
cancer [52].
Limitations
Eighteen HCPs were recruited into the study however the
majority who participated in the focus groups were nurs-
ing staff (n = 13). Increased numbers of allied HCPs and
medical staff may have provided more diverse perspec-
tives. Only a small number of participants had cared for
someone with a diagnosis of ILD (n = 4) or bronchiectasis
(n = 1). Recruiting greater numbers from these disease
groups may have provided further perspectives. Findings
also only represented the perspectives of carers and HCPs
and not the patient’s own perspective. It is also recognised
that bereaved carers were recruited through the RNS
which makes the sample less representative of patients
with NMRD who do not receive RNS care.
Conclusions
The management of patients with NMRD is complex
and challenging with a clear need for a stronger and
more integrative model of practice, which incorpo-
rates palliative care in a responsive and dynamic way.
This study has reinforced the importance of proactive
palliative care that identifies the needs of the individ-
ual patient and is not influenced by their prognosis.
Future care to patients with NMRD must also
acknowledge the important role of palliative care and
generalist palliative care providers must have access
to specialist input and advice when needed. This
Fig. 3 Model of palliative care for patients with non-malignant respiratory disease
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study also adds a novel perspective in identifying a
potential model of palliative care for NMRD that may
enhance future holistic care for this client group. The
feasibility of integrating this model into clinical prac-
tice requires further exploration.
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